Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02592135 · ClinicalTrials.gov registry record
High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 500
- Enrollment target
NCT02592135: Completed study, sponsored by Indiana University.
NCT02592135 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02592135 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand myocardial injury in AHF. Secondary analyses demonstrate the prognostic significance of troponin release. The absence of such release has been associated with less risk. Whether measurement of high sensitivity TnT may enable emergency physicians to better risk stratify acute heart failure patients remains to be determined. This study will help us to better understand the prognostic value of absent or low hsTnT values in the emergency department setting. In addition, we will also test the STRATIFY decision rule; a risk score.
Primary Outcome
Have increased the follow up from 30 to 90 days. Will also analyze for 30 days
Interventions
- OTHER hsTnT level
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2015-12-21 |
| Est. Completion | 2018-05-31 |
What the finished NCT02592135 record still lists
NCT02592135 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which hsTnT level is the first listed.
NCT02592135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02592135 about?
NCT02592135 is a clinical study titled "High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)". The purpose of this study is to better understand myocardial injury in AHF. Secondary analyses demonstrate the prognostic significance of troponin release. The absence of such release has been associated with less risk. Whether measurement of high sensitivity TnT may enable emergency physicians to b...
What is the current status of trial NCT02592135?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2015-12-21. Estimated completion is 2018-05-31.
What interventions are being tested in trial NCT02592135?
The interventions under investigation include: hsTnT level (OTHER).
Who is sponsoring clinical trial NCT02592135?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI